Zhejiang Hisun Pharmaceutical Co. Ltd.

For profitWebsite ↗

Also known as: HISUN PHARM HANGZHOU | Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd | ZHEJIANG HISUN PHARM | Zhejiang Hisun Pharmaceutical Co. Ltd. | Zhejiang Hisun Pharmaceuticals Co., Ltd

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Nov 1, 2013

First marketed drug

Jan 28, 2009

Last known activity

Jan 21, 2026

Timeline

1950s

Jan 1, 1956
Zhejiang Hisun Pharmaceutical Co. Ltd.— Founded

2010s

Feb 13, 2012
Respirics Inc.— Acquired
Apr 12, 2019
daunorubicin— Marketing Organization

Drugs by trial phase (28 distinct, 23 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (11 own, 0 via acquisition)

Phase 2 (8 own, 0 via acquisition)

Phase 1 (6 own, 1 via acquisition)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Respirics Inc.

Recent trials (24)

NCT07310173Lead sponsorPhase 2Jan 1, 2026
NCT07092748Lead sponsorPhase 1Jul 15, 2025
NCT05351697Lead sponsorPhase 1Apr 30, 2022
NCT05323981Lead sponsorPhase 1Apr 8, 2022
NCT05058352Lead sponsorPhase 1Oct 31, 2021
NCT06048224Lead sponsorPhase 3Dec 28, 2020
NCT04514419Lead sponsorPhase 3Jun 30, 2020
NCT04425460Lead sponsorPhase 3Jun 30, 2020
NCT04361812Lead sponsorPhase 1Jun 8, 2020
NCT03790982Lead sponsorPhase 2Dec 1, 2018
NCT03625401Study directorPhase 2Aug 12, 2018
NCT03625401Lead sponsorPhase 2Aug 12, 2018
NCT06107790Lead sponsorPhase 3May 16, 2018
NCT03755258Lead sponsorPhase 1Mar 16, 2017
NCT03433196Lead sponsorPhase 3Jun 7, 2016

Details

Founded: Taizhou, CN Jan 1, 1956
Last known activity: Jan 21, 2026